The ADAMTSL2 Gene Geleophysic Dysplasia Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the ADAMTSL2 gene, which are responsible for Geleophysic Dysplasia Type 1, a rare genetic disorder characterized by short stature, short hands and feet, and distinctive facial features. The condition can also affect the heart, bones, and other organs, making early diagnosis crucial for managing symptoms and improving the quality of life for those affected.
DNA Labs UAE employs advanced genetic testing techniques to accurately analyze the ADAMTSL2 gene, ensuring reliable results for patients and their families. The test is priced at 4400 AED, reflecting the sophisticated technology and expertise required to conduct this complex analysis. By opting for this test, individuals can gain vital insights into their genetic makeup, enabling informed decisions about their health and future.
The GORAB Gene Geroderma Osteodysplasticum Genetic Test is a specialized diagnostic tool designed to identify mutations in the GORAB gene, which are linked to Geroderma Osteodysplasticum (GO). GO is a rare genetic disorder characterized by skin laxity, growth retardation, and skeletal abnormalities. This condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
Conducted at DNA Labs UAE, this test is pivotal for early diagnosis and management of the disorder. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed to detect the presence of specific mutations in the GORAB gene that are known to cause the condition.
The cost of the GORAB Gene Geroderma Osteodysplasticum Genetic Test is set at 4400 AED. While the price may seem steep, the value of this test lies in its ability to provide essential information for the accurate diagnosis and treatment planning for individuals suspected of having this rare condition. Early diagnosis can significantly influence the management and quality of life of the affected individuals, making this test a crucial step for families with a history of Geroderma Osteodysplasticum.
Ghosal Hematodiaphyseal Syndrome (GHDS) is a rare genetic disorder characterized by bone marrow fibrosis and abnormal bone development, leading to a variety of skeletal abnormalities. This condition is caused by mutations in the TBXAS1 gene, which plays a crucial role in bone and blood vessel development. Individuals with GHDS may experience symptoms such as anemia, bone pain, and increased bone density, particularly in the diaphyses of long bones.
To diagnose GHDS, genetic testing for mutations in the TBXAS1 gene is essential. DNA Labs UAE offers a specific genetic test targeting the TBXAS1 gene to confirm the diagnosis of Ghosal Hematodiaphyseal Syndrome. The test involves analyzing the patient's DNA to identify mutations in the TBXAS1 gene that are known to cause the syndrome.
The cost of the TBXAS1 gene genetic test at DNA Labs UAE is 4400 AED. This test is a critical step in the diagnostic process for individuals suspected of having GHDS, as a confirmed genetic diagnosis can help in managing the condition effectively. It involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the laboratory for the presence of specific mutations associated with the syndrome.
Early diagnosis through genetic testing can facilitate timely intervention and management strategies, potentially improving the quality of life for individuals with Ghosal Hematodiaphyseal Syndrome.
The ANO5 gene gnathodiaphyseal dysplasia genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ANO5 gene, which are responsible for causing gnathodiaphyseal dysplasia. This rare genetic disorder is characterized by bone fragility, sclerosis of tubular bones, and cemento-osseous lesions of the jawbones, leading to frequent bone fractures and jawbone dysmorphisms. The test plays a crucial role in the early detection and management of the condition, allowing for personalized treatment plans and genetic counseling for affected families. Priced at 4400 AED, this test is a valuable resource for individuals exhibiting symptoms of gnathodiaphyseal dysplasia or those with a family history of the condition, aiming to provide them with accurate diagnoses and insights into their genetic health.
The FAM111A gene plays a critical role in the development and maintenance of bones, and mutations in this gene can lead to gracile bone dysplasia, a rare genetic disorder characterized by thin, fragile bones that are prone to fractures. To diagnose this condition, a genetic test targeting the FAM111A gene is available, offering a definitive way to identify mutations associated with gracile bone dysplasia. This test is particularly important for families with a history of the condition or for individuals presenting symptoms suggestive of the disorder.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides a comprehensive analysis of the FAM111A gene to detect any abnormalities that could indicate the presence of gracile bone dysplasia. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies to identify mutations in the FAM111A gene.
The cost of the FAM111A gene test for gracile bone dysplasia at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately detect and interpret mutations in the gene. Upon completion of the test, patients receive a detailed report that explains the findings and, if a mutation is detected, outlines the implications for the patient's health and potential treatment or management options. This information can be crucial for making informed decisions about care and for understanding the risk of passing the condition on to future generations.
The NCF1 gene plays a crucial role in the immune system, particularly in the function of neutrophils, which are white blood cells that help fight infections. Mutations in the NCF1 gene can lead to Granulomatous Disease, Chronic, Autosomal Recessive, Cytochrome b-Positive, Type 1 (CGD), a rare genetic disorder. This condition is characterized by the body's inability to effectively kill certain bacteria and fungi, leading to recurrent infections and the formation of granulomas, which are clusters of immune cells that form at sites of infection or inflammation.
To diagnose this specific type of CGD, genetic testing is essential. DNA Labs UAE offers a comprehensive genetic test that analyzes the NCF1 gene to identify mutations associated with this condition. The test is priced at 4400 AED and is a crucial step for families seeking answers to persistent, unexplained infections or immune system issues. The results can provide a definitive diagnosis, guiding treatment options and management strategies for affected individuals. Genetic testing for CGD not only helps in managing the condition but also aids in family planning and understanding the risk of passing the genetic mutation to future generations.
The "CYBA Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Negative Genetic Test" is a specialized diagnostic examination designed to identify mutations in the CYBA gene. This gene plays a critical role in the proper functioning of the immune system, specifically in the production of cytochrome b-558, a component essential for the respiratory burst in phagocytes. Mutations in the CYBA gene can lead to a form of Chronic Granulomatous Disease (CGD), an autosomal recessive condition characterized by the immune system's inability to effectively combat certain bacteria and fungi, leading to repeated infections and the formation of granulomas.
This genetic test is crucial for the early detection and management of CGD, enabling healthcare providers to tailor treatments that can significantly improve the quality of life for affected individuals. The test involves analyzing the patient's DNA to look for abnormalities in the CYBA gene that would confirm the diagnosis of CGD.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides a comprehensive analysis with high accuracy. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this detailed genetic analysis. Early diagnosis through this test can lead to better management of the disease, potentially preventing severe infections and other complications associated with CGD.
The NCF2 gene plays a critical role in the immune system's ability to combat infections. Mutations in this gene can lead to a condition known as Chronic Granulomatous Disease (CGD) of the autosomal recessive cytochrome b-positive type 2. CGD is a rare immune disorder characterized by the body's inability to effectively kill certain bacteria and fungi, leading to repeated infections and the formation of granulomas, which are clusters of immune cells that form at sites of infection or inflammation.
The genetic test for identifying mutations in the NCF2 gene is crucial for the diagnosis and management of CGD. Conducted at DNA Labs UAE, this test is designed to detect specific genetic alterations in the NCF2 gene that are responsible for the condition. By identifying these mutations, healthcare providers can confirm a diagnosis of CGD, enabling them to tailor treatment plans to the individual needs of the patient, potentially improving outcomes and quality of life.
The cost of the NCF2 gene test at DNA Labs UAE is 4400 AED. This test is an important tool for families with a history of CGD or for individuals presenting symptoms suggestive of the disease. Early diagnosis through genetic testing can facilitate timely and appropriate medical interventions, including prophylactic antibiotics, antifungal medications, and potentially gene therapy or bone marrow transplantation, which are considered for severe cases.
The NCF4 gene plays a crucial role in the immune system, particularly in the functioning of neutrophils, which are a type of white blood cell essential for combating infections. Mutations in the NCF4 gene can lead to Granulomatous Disease Chronic, Autosomal Recessive, Cytochrome b-Positive, Type 3 (CGD). This condition is characterized by the body's inability to effectively kill certain bacteria and fungi, leading to recurrent and severe infections. The disease can manifest in various ways, including persistent skin and organ infections, granuloma formation, and other complications.
Genetic testing for mutations in the NCF4 gene is crucial for diagnosing this specific type of CGD. At DNA Labs UAE, a comprehensive genetic test is available for individuals suspected of having this condition or for those carrying a family history of CGD. The test involves analyzing the patient's DNA to identify mutations in the NCF4 gene that are known to cause the disease.
The cost of the NCF4 gene test at DNA Labs UAE is 4400 AED. This investment covers the expenses of the genetic analysis, including the collection of a DNA sample, usually through a blood draw or cheek swab, and the detailed examination of the NCF4 gene for any mutations. The results from this test can provide crucial information for the diagnosis, management, and treatment of CGD, helping affected individuals and their families make informed health decisions.
The CYBB gene, associated with Chronic Granulomatous Disease (CGD), plays a crucial role in the body's immune system by helping white blood cells kill bacteria and fungi. CGD is a rare genetic disorder that impairs the body's ability to fight infections, leading to severe and recurrent infections. It is most commonly inherited in an X-linked manner, affecting mainly males.
At DNA Labs UAE, individuals concerned about CGD can undergo a genetic test specifically designed to identify mutations in the CYBB gene, which is responsible for the X-linked form of the disease. This test is essential for the accurate diagnosis of CGD, enabling early intervention and management of the condition to improve the quality of life for affected individuals.
The cost of the CYBB gene granulomatous disease chronic X-linked genetic test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted by highly qualified professionals using state-of-the-art technology to ensure reliable and accurate results. By choosing to undergo this test, individuals can gain valuable insights into their genetic health, paving the way for personalized medical care and informed family planning decisions.
